Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users

被引:103
|
作者
Spijkerman, IJB
vanAmeijden, EJC
Mientjes, GHC
Coutinho, RA
vandenHoek, A
机构
[1] Municipal Health Service, Dept. of Pub. Health and Environment, Amsterdam
[2] Municipal Health Service, Dept. of Pub. Health and Environment, 1000 HE Amsterdam
关键词
intravenous drug abuse; HIV; skin diseases; abscesses; endocarditis; risk factors;
D O I
10.1016/0895-4356(96)00180-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: to study incidence rates of and risk factors for skin abscesses at the site of injection and episodes of endocarditis among injection drug users (IDU). Design: A comprehensive, open cohort study of drug users on the natural history of human immunodeficiency virus (HIV) infection. Methods: From 1986 to 1994, injection drug users in Amsterdam were included in the study. Incidence rates of self-reported skin abscesses and verified episodes of endocarditis were calculated, In uni- and multivariate Poisson regression analysis, risk factors for skin abscesses and endocarditis were determined. Results: 521 HIV-seronegative and 237 HIV-seropositive IDU were followed for 1640 person-years, A total of 545 skin abscesses were reported by 269 IDU (incidence 33/100 person-years). HIV infection, female gender, prostitution among females, foreign nationality, injection of heroin and cocaine, a high frequency of injecting, and obtaining syringes through the needle exchange program were independently and positively associated with skin abscesses. During follow-up, 17 verified episodes of endocarditis were observed (incidence 1.3/100 person-years). Endocarditis was independently associated with HIV infection and a previous history of endocarditis. Furthermore, women and IDU with a skin abscess appeared to be at an increased risk for endocarditis. Conclusions: HIV infection is an independent risk factor for skin abscesses and endocarditis. Also, women are at an increased risk for these injection related infections. Prevention activities, like promotion of skin cleaning, should be directed at those IDU in whom one or more risk factors have been identified.
引用
收藏
页码:1149 / 1154
页数:6
相关论文
共 50 条
  • [21] Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
    Javadi, Abbasali
    Ataei, Behrooz
    Kassaian, Nazila
    Nokhodian, Zary
    Yaran, Majid
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 : S17 - S21
  • [22] Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment
    Backmund, M
    Reimer, J
    Meyer, K
    Gerlach, JT
    Zachoval, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 : S330 - S335
  • [23] Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity
    Markus Backmund
    Kirsten Meyer
    Martin Wächtler
    Dieter Eichenlaub
    [J]. European Journal of Epidemiology, 2003, 18 (6) : 563 - 568
  • [24] Hepatitis C virus infection in injection drug users in Bavaria:: Risk factors for seropositivity
    Backmund, M
    Meyer, K
    Wächtler, M
    Eichenlaub, D
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2003, 18 (06) : 563 - 568
  • [25] EFFECT OF PSYCHOLOGICAL-FACTORS ON RISK BEHAVIOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION AMONG INTRAVENOUS-DRUG-USERS (IVDUS)
    NEMOTO, T
    FOSTER, K
    BROWN, LS
    [J]. INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1991, 26 (04): : 441 - 456
  • [26] Dynamics of SEN virus infection among injection drug users
    Wilson, LE
    Umemura, T
    Astemborski, J
    Ray, SC
    Alter, HJ
    Strathdee, SA
    Vlahov, D
    Thomas, DL
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1158 - 1158
  • [27] Dynamics of SEN virus infection among injection drug users
    Wilson, LE
    Umemura, T
    Astemborski, J
    Ray, SC
    Alter, HJ
    Strathdee, SA
    Vlahov, D
    Thomas, DL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1315 - 1319
  • [28] Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection
    Vlahov, D
    Galai, N
    Safaeian, M
    Galea, S
    Kirk, GD
    Lucas, GM
    Sterling, TR
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : 999 - 1012
  • [29] Vitamin A levels and human immunodeficiency virus load in injection drug users
    Semba, RD
    Farzadegan, H
    Vlahov, D
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (01) : 93 - 95
  • [30] Vitamin A supplementation and human immunodeficiency virus load in injection drug users
    Semba, RD
    Lyles, CM
    Margolick, JB
    Caiaffa, WT
    Farzadegan, H
    Cohn, S
    Vlahov, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03): : 611 - 616